{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:36:07Z","timestamp":1793280967674,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jaad.2016.12.035","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T17:30:14Z","timestamp":1486747814000},"page":"1161-1175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90\u00a0years of debate"],"prefix":"10.1016","volume":"76","author":[{"given":"Joanna","family":"Przybyszewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Zlotogorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Ramot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.12.035_bib1","first-page":"923","article-title":"Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model","volume":"194","author":"Orth","year":"2010","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.jaad.2016.12.035_bib2","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1038\/cddis.2013.27","article-title":"EVER2 protein binds TRADD to promote TNF-alpha-induced apoptosis","volume":"4","author":"Gaud","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaad.2016.12.035_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-4632.2004.01558.x","article-title":"Why epidermodysplasia verruciformis - a rare genetic disease - has raised such great interest","volume":"43","author":"Majewski","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.035_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/01.SMJ.0000054544.47233.7C","article-title":"Epidermodysplasia verruciformis","volume":"96","author":"Lane","year":"2003","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2016.12.035_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/QCO.0b013e3282f486c9","article-title":"Epidermodysplasia verruciformis and human papilloma virus","volume":"21","author":"Gewirtzman","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jaad.2016.12.035_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000356068","article-title":"Epidermodysplasia verruciformis","volume":"45","author":"Burger","year":"2014","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.jaad.2016.12.035_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2013.06.007","article-title":"Diseases associated with human papillomavirus infection","volume":"445","author":"Cubie","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jaad.2016.12.035_bib8","first-page":"145","article-title":"Cutaneous manifestations of human\u00a0papillomaviruses: a review","volume":"20","author":"Cardoso","year":"2011","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.jaad.2016.12.035_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00105-010-2030-8","article-title":"Biology of epidermodysplasia verruciformis-associated HPV","volume":"62","author":"Pfister","year":"2011","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2016.12.035_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1155\/2010\/345436","article-title":"Epidermodysplasia verruciformis and susceptibility to HPV","volume":"29","author":"Patel","year":"2010","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000321880","article-title":"Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms","volume":"222","author":"Mertz","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/pde.12130","article-title":"Merkel cell polyomavirus detection in a patient with familial epidermodysplasia verruciformis","volume":"30","author":"Kwon","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2016.12.035_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000335151","article-title":"Human papillomavirus and squamous cell cancer of the skin\u2013epidermodysplasia verruciformis-associated human papillomavirus revisited","volume":"43","author":"Arnold","year":"2012","journal-title":"Curr Probl Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5114\/ada.2016.59145","article-title":"The EVER genes \u2013 the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients","volume":"33","author":"Kali\u0144ska-Bienias","year":"2016","journal-title":"Postepy Dermatol Alergol"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib15","first-page":"E10","article-title":"Epidermodysplasia verruciformis and the risk for malignancy","volume":"98","author":"Fox","year":"2016","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/09546630310009699","article-title":"Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin","volume":"14","author":"Gubinelli","year":"2003","journal-title":"J Dermatolog Treat"},{"issue":"5 Suppl","key":"10.1016\/j.jaad.2016.12.035_bib17","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1016\/S0190-9622(03)00465-1","article-title":"Ocular and cutaneous squamous cell carcinoma in an African American man with epidermodysplasia verruciformis resulting in blindness and death","volume":"49","author":"Partridge","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"1 Suppl","key":"10.1016\/j.jaad.2016.12.035_bib18","doi-asserted-by":"crossref","first-page":"18s","DOI":"10.1038\/jid.1984.15","article-title":"Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses","volume":"83","author":"Lutzner","year":"1984","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1155\/2007\/942650","article-title":"Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations","volume":"23","author":"Nindl","year":"2007","journal-title":"Dis Markers"},{"issue":"6","key":"10.1016\/j.jaad.2016.12.035_bib20","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.0022-202X.2004.22617.x","article-title":"Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus","volume":"122","author":"Termorshuizen","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2016.12.035_bib21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1365-4362.1998.00399.x","article-title":"Epidermodysplasia verruciformis with neurological manifestations","volume":"37","author":"Al Rubaie","year":"1998","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000249578","article-title":"A case of epidermodysplasia verruciformis (Lewandowsky-Lutz, 1922) with skin cancer: histopathology of malignant cutaneous changes","volume":"169","author":"Tanigaki","year":"1984","journal-title":"Dermatologica"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/jcm.34.2.369-375.1996","article-title":"Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs","volume":"34","author":"Adachi","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0042-6822(85)90328-9","article-title":"Human papillomavirus type 17 DNA in skin carcinoma tissue of a patient with epidermodysplasia verruciformis","volume":"144","author":"Yutsudo","year":"1985","journal-title":"Virology"},{"issue":"4 Suppl 1","key":"10.1016\/j.jaad.2016.12.035_bib25","first-page":"S57","article-title":"Epidermodysplasia verruciformis: clinical presentation with varied forms of lesions","volume":"86","author":"Sa","year":"2011","journal-title":"An Bras Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2016.12.035_bib26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-4632.2006.03014.x","article-title":"Clinical aspects of epidermodysplasia verruciformis and review of the literature","volume":"46","author":"Gul","year":"2007","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000372-199302000-00001","article-title":"Seborrheic keratoses of black patients with epidermodysplasia verruciformis contain human papillomavirus DNA","volume":"15","author":"Jacyk","year":"1993","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1989.tb15513.x","article-title":"Types of human papillomavirus isolated from Japanese patients with epidermodysplasia verruciformis","volume":"121","author":"Kanda","year":"1989","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2016.12.035_bib29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-4362.1993.tb02768.x","article-title":"Epidermodysplasia verruciformis in Africans","volume":"32","author":"Jacyk","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.035_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01938833","article-title":"Ein Fall einer bisher nicht beschriebenen Hauterkrankung","volume":"141","author":"Lewandowsky","year":"1922","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/j.jaad.2016.12.035_bib31","first-page":"59","article-title":"Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis","volume":"321","author":"Orth","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20071311","article-title":"Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses","volume":"205","author":"Lazarczyk","year":"2008","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2006.08.013","article-title":"Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis","volume":"44","author":"Zuo","year":"2006","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1346-8138.2003.tb00372.x","article-title":"Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis","volume":"30","author":"Pereira de Oliveira","year":"2003","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1044","article-title":"Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis","volume":"32","author":"Ramoz","year":"2002","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng842","article-title":"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function","volume":"30","author":"Kurima","year":"2002","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng848","article-title":"Beethoven, a mouse model for dominant, progressive hearing loss DFNA36","volume":"30","author":"Vreugde","year":"2002","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10875-012-9749-1","article-title":"EVER2 deficiency is associated with mild T-cell abnormalities","volume":"33","author":"Crequer","year":"2013","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2016.12.035_bib39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1523-1747.ep12491539","article-title":"TGF beta-1 and TNF alpha expression in the epidermis of patients with epidermodysplasia verruciformis","volume":"97","author":"Majewski","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2016.12.035_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.smim.2006.07.008","article-title":"Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses","volume":"18","author":"Orth","year":"2006","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1525-1470.2008.00853.x","article-title":"Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation","volume":"26","author":"McDermott","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2016.12.035_bib42","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archderm.1985.01660070054014","article-title":"X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred","volume":"121","author":"Androphy","year":"1985","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2016.12.035_bib43","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1172\/JCI62949","article-title":"Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections","volume":"122","author":"Crequer","year":"2012","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.jaad.2016.12.035_bib44","doi-asserted-by":"crossref","first-page":"e44010","DOI":"10.1371\/journal.pone.0044010","article-title":"Inherited MST1 deficiency underlies susceptibility to EV-HPV infections","volume":"7","author":"Crequer","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jaad.2016.12.035_bib45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10875-014-0074-8","article-title":"Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy","volume":"34","author":"Stray-Pedersen","year":"2014","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.jaad.2016.12.035_bib46","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2015.02.1118","article-title":"Generalized verrucosis and HPV-3 susceptibility associated with CD4 T-cell lymphopenia caused by inherited human interleukin-7 deficiency","volume":"72","author":"Horev","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.12.035_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1478-811X-6-6","article-title":"The small GTPase RhoH is an atypical regulator of haematopoietic cells","volume":"6","author":"Fueller","year":"2008","journal-title":"Cell Commun Signal"},{"issue":"9","key":"10.1016\/j.jaad.2016.12.035_bib48","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri2606","article-title":"Rho family GTPases and their regulators in lymphocytes","volume":"9","author":"Tybulewicz","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.jaad.2016.12.035_bib49","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nri1646","article-title":"Intracellular signalling controlling integrin activation in lymphocytes","volume":"5","author":"Kinashi","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2016.12.035_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/978-0-387-09595-0_12","article-title":"The role of mammalian coronins in development and disease","volume":"48","author":"Roadcap","year":"2008","journal-title":"Subcell Biochem"},{"issue":"5","key":"10.1016\/j.jaad.2016.12.035_bib51","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.3390\/ijms160510267","article-title":"Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy","volume":"16","author":"Gao","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"4-5","key":"10.1016\/j.jaad.2016.12.035_bib52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cytogfr.2005.05.004","article-title":"Cell biology of IL-7, a key lymphotrophin","volume":"16","author":"Jiang","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.1999.00536.x","article-title":"A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus","volume":"112","author":"Ramoz","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.bjc.6606011","article-title":"Mst1\/2 signalling to Yap: gatekeeper for liver size and tumour development","volume":"104","author":"Avruch","year":"2011","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2016.12.035_bib55","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cell.2011.02.031","article-title":"Yap1 acts downstream of alpha-catenin to control epidermal proliferation","volume":"144","author":"Schlegelmilch","year":"2011","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.jaad.2016.12.035_bib56","doi-asserted-by":"crossref","first-page":"E1473","DOI":"10.1073\/pnas.1205991109","article-title":"Cutaneous beta-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling","volume":"109","author":"Tan","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2008.08.035","article-title":"Acquired epidermodysplasia verruciformis","volume":"60","author":"Rogers","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib58","first-page":"353","article-title":"Acquired epidermodysplasia verruciformis in an HIV-infected patient","volume":"12","author":"Broekaert","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"10.1016\/j.jaad.2016.12.035_bib59","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1093\/cid\/cis118","article-title":"Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe","volume":"54","author":"Lowe","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jaad.2016.12.035_bib60","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/1346-8138.13262","article-title":"Acquired epidermodysplasia verruciformis associated with human papillomavirus type\u00a047 in a HIV-infected patient","volume":"43","author":"Ashida","year":"2016","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib61","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000235743","article-title":"Epidermodysplasia-verruciformis-like eruption associated with gamma-papillomavirus infection in a patient with adult T-cell leukemia","volume":"219","author":"Kawai","year":"2009","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000249701","article-title":"Epidermodysplasia verruciformis in lepromatous leprosy. Report of 2 cases","volume":"168","author":"Jacyk","year":"1984","journal-title":"Dermatologica"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/pde.12124","article-title":"Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology","volume":"32","author":"O'Blenes","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2016.12.035_bib64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00277-015-2329-8","article-title":"Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustine","volume":"94","author":"Cougoul","year":"2015","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1525-1470.2012.01822.x","article-title":"Acquired epidermodysplasia verruciformis in a child with atopic dermatitis","volume":"31","author":"Fernandez","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"5 Suppl","key":"10.1016\/j.jaad.2016.12.035_bib66","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jaad.2006.04.035","article-title":"Epidermodysplasia verruciformis in the setting of graft-versus-host disease","volume":"57","author":"Kunishige","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1440-0960.2008.00502.x","article-title":"Epidermodysplasia verruciformis-like syndrome in association with systemic lupus erythematosus","volume":"50","author":"Holmes","year":"2009","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jama.1974.03230420031020","article-title":"Cutaneous complications in immunosuppressed renal homograft recipients","volume":"229","author":"Koranda","year":"1974","journal-title":"JAMA"},{"issue":"8347","key":"10.1016\/j.jaad.2016.12.035_bib69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(83)90389-6","article-title":"Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient","volume":"2","author":"Lutzner","year":"1983","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/1523-1747.ep12531131","article-title":"A Potentially Oncogenic Human Papillomavirus (HPV-5) Found in Two Renal Allograft Recipients","volume":"75","author":"Lutzner","year":"1980","journal-title":"J Investig Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib71","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0190-9622(08)80878-X","article-title":"Epidermodysplasia verruciformis associated with severe immunodeficiency, lymphoma, and disseminated molluscum contagiosum","volume":"27","author":"Slawsky","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2016.12.035_bib72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2310\/7750.2009.08049","article-title":"Epidermodysplasia verruciformis associated with myelodysplastic syndrome: an intriguing association","volume":"13","author":"Oliveira","year":"2009","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib73","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000174084","article-title":"Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A\u2013>T polymorphism in the TMC8\/EVER2 gene","volume":"218","author":"Hohenstein","year":"2009","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jaad.2016.12.035_bib74","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1111\/pde.12164","article-title":"Acquired epidermodysplasia verruciformis in a child with the human immunodeficiency virus","volume":"30","author":"Cowan","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2016.12.035_bib75","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archdermatol.2010.399","article-title":"Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy","volume":"147","author":"Jacobelli","year":"2011","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib76","first-page":"169","article-title":"Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis","volume":"65","author":"Lutzner","year":"1978","journal-title":"Bull Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib77","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-4362.2003.01707_2.x","article-title":"Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy","volume":"42","author":"Carre","year":"2003","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2133.1998.02328.x","article-title":"Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection","volume":"139","author":"Barzegar","year":"1998","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2133.1991.tb03286.x","article-title":"Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease","volume":"124","author":"Berger","year":"1991","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib80","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archdermatol.2011.268","article-title":"Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization","volume":"148","author":"Moore","year":"2012","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib81","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaad.2010.12.011","article-title":"Generalized verrucosis: a review of the associated diseases, evaluation, and treatments","volume":"66","author":"Sri","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2016.12.035_bib82","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1034\/j.1600-0560.2002.290806.x","article-title":"The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients","volume":"29","author":"Morrison","year":"2002","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib83","first-page":"261","article-title":"A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin","volume":"10","author":"Ansarin","year":"2007","journal-title":"Arch Iran Med"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib84","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1067\/mjd.2001.114575","article-title":"Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a","volume":"45","author":"Anadolu","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2016.12.035_bib85","first-page":"903","article-title":"What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?","volume":"146","author":"Lee","year":"2010","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib86","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/abd1806-4841.20142803","article-title":"Acquired epidermodysplasia verruciformis in a renal transplant recipient\u2013case report","volume":"89","author":"Mendes","year":"2014","journal-title":"An Bras Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaad.2010.06.007","article-title":"Merkel cell carcinoma presenting in a young patient as a forme fruste of variant epidermodysplasia verruciformis","volume":"65","author":"Halvorson","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2016.12.035_bib88","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/dsu.12135","article-title":"Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment","volume":"39","author":"Zampetti","year":"2013","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib89","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2133.2001.04426.x","article-title":"Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient","volume":"145","author":"Haas","year":"2001","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2016.12.035_bib90","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9","article-title":"WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies","volume":"91","author":"Gorlin","year":"2000","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.jaad.2016.12.035_bib91","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOH.0b013e32831ac557","article-title":"WHIM syndrome: congenital immune deficiency disease","volume":"16","author":"Kawai","year":"2009","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib92","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archderm.144.3.366","article-title":"A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome","volume":"144","author":"Kreuter","year":"2008","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2016.12.035_bib93","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","article-title":"Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies","volume":"127","author":"Rezaei","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2016.12.035_bib94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2249.2000.01359.x","article-title":"Severe combined immunodeficiencies (SCID)","volume":"122","author":"Fischer","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.jaad.2016.12.035_bib95","first-page":"527","article-title":"Groin eruption in an HIV-positive man: epidermodysplasia verruciformis (EDV)","volume":"138","author":"Trauner","year":"2002","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.12.035_bib96","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2230.2006.02100.x","article-title":"Epidermodysplasia verruciformis and generalized verrucosis:\u00a0the same disease?","volume":"31","author":"Yanagi","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2016.12.035_bib97","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/bjd.14679","article-title":"Identification of LCK mutation\u00a0in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma","volume":"175","author":"Li","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.035_bib98","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaci.2016.07.024","article-title":"Epidermodysplasia verruciformis as a manifestation of ARTEMIS deficiency in\u00a0a\u00a0young adult","volume":"139","author":"Tahiat","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:41:31Z","timestamp":1759272091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216312968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0190962216312968"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.035","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90\u00a0years of debate","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}